参考文献/References:
[1] Wu C, Li F, Niu G, et al. PET imaging of inflammation biomarkers[J]. Theranostics, 2013, 3(7):448-466. DOI:10.7150/thno.6592.
[2] Li J, Zhang Y, Chordia MD, et al. Multimodal formyl peptide receptor 1 targeted inflammation imaging probe:cFLFLF-MHI-DOTA[J]. Bioorg Med Chem Lett, 2016, 26(3):1052-1055. DOI:10.1016/j.bmcl.2015.12.029.
[3] 付占立. 炎症显像剂的临床应用及研究进展[J]. 同位素, 2010, 23(3):186-192. Fu ZL. Clinical Application and Progress in Research of Inflammation Imaging Agent[J]. J Isotopes, 2010, 23(3):186-192.
[4] Virtanen H, Silvola JMU, Autio A, et al. Comparison of 68Ga-DOTA-Siglec-9 and 18F-Fluorodeoxyribose-Siglec-9:Inflammation Imaging and Radiation Dosimetry[J/OL]. Contrast Media Mol Imaging, 2017, 2017:7645070[2018-02-03]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804415. DOI:10.1155/2017/7635070.
[5] 朱文佳, 要少波, 邢海群, 等. 核医学炎症显像病原菌特异性示踪剂研究进展[J]. 中国医学影像学杂志, 2016, 24(9):710-713. DOI:10.3969/j.issn.1005-5185.2016.09.020. Zhu WJ, Yao SB, Xing HQ, et al. Progress in Research of Pathogen-specific Tracers for Inflammation Imaging in Nuclear Medicine[J]. Chin J Med Imaging, 2016, 24(9):710-713.
[6] Goldsmith SJ, Vallabhajosula S. Clinically proven radiopharmaceu-ticals for infection imaging:mechanisms and applications[J]. Semin Nucl Med, 2009, 39(1):2-10. DOI:10.1053/j.semnuclmed. 2008. 08.002.
[7] Bhargava KK, Gupta RK, Nichols KJ, et al. In vitro human leukocyte labeling with 64Cu:an intraindividual comparison with 111In-oxine and 18F-FDG[J]. Nucl Med Biol, 2009, 36(5):545-549. DOI:10.1016/j.nucmedbio.2009.03.001.
[8] Tseng JC, Kung AL. In vivo imaging method to distinguish acute and chronic inflammation[J/OL]. J Vis Exp, 2013, 78:e50690[2018-02-03]. https://www.ncbi.nlm.nih.gov/pubmed/23978851. DOI:10.3791/50690.
[9] Palestro CJ, Love C, Bhargava KK. Labeled leukocyte imaging:current status and future directions[J]. Q J Nucl Med Mol Imaging, 2009, 53(1):105-123.
[10] Boerman OC, Dams ET, Oyen WJ, et al. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation[J]. Inflamm Res, 2001, 50(2):55-64. DOI:10.1007/s000110050725.
[11] Osman S, Danpure HJ. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography[J]. Int J Rad Appl Instrum B, 1992, 19(2):183-190.
[12] Rini JN, Bhargava KK, Tronco GG, et al. PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection[J]. Radiology, 2006, 238(3):978-987. DOI:10.1148/radiol.2382041993.
[13] Yilmaz S, Aliyev A, Ekmekcioglu O, et al. Comparison of FDG and FDG-labeled leukocytes PET/CT in diagnosis of infection[J]. Nuklearmedizin, 2015, 54(6):262-271. DOI:10.3413/Nukmed-0724-15-02.
[14] Bhattacharya A, Kochhar R, Sharma S, et al. PET/CT with 18F-FDG-labeled autologous leukocytes for the diagnosis of infected fluid collections in acute pancreatitis[J]. J Nucl Med, 2014, 55(8):1267-1272. DOI:10.2967/jnumed.114.137232.
[15] Dumarey N. Imaging with FDG labeled leukocytes:is it clinically useful?[J]. Q J Nucl Med Mol Imaging, 2009, 53(1):89-94.
[16] Klett R, Kordelle J, Stahl U, et al. Immunoscintigraphy of septic loosening of knee endoprosthesis:a retrospective evaluation of the antigranulocyte antibody BW 250/183[J]. Eur J Nucl Med Mol Imaging, 2003, 30(11):1463-1466. DOI:10.1007/s00259-003-1275-1.
[17] Akhtar MS, Imran MB, Nadeem MA, et al. Antimicrobial peptides as infection imaging agents:better than radiolabeled antibiotics[J]. Int J Pept, 2012, 2012:965238. DOI:10.1155/2012/965238.
[18] Thakur ML, Marcus CS, Kipper SL, et al. Imaging infection with LeuTech[J]. Nucl Med Commun, 2001, 22(5):513-519.
[19] Xing D, Ma X, Ma J, et al. Use of anti-granulocyte scintigraphy with 99mTc-labeled monoclonal antibodies for the diagnosis of periprosthetic infection in patients after total joint arthroplasty:a diagnostic meta-analysis[J/OL]. PLoS One, 2013, 8(7):e69857[2018-02-03]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724677/. DOI:10.1371/journal.pone.0069857.
[20] Richter WS, Ivancevic V, Meller J, et al. 99mTc-besilesomab (Scintimun) in peripheral osteomyelitis: comparison with 99mTc-labelled white blood cells[J]. Eur J Nucl Med Mol Imaging, 2011, 38(5):899-910. DOI:10.1007/s00259-011-1731-2.
[21] Thakur ML, Marcus CS, Henneman P, et al. Imaging inflammatory diseases with neutrophil-specific technetium-99m-labeled monoclonal antibody anti-SSEA-1[J]. J Nucl Med, 1996, 37(11):1789-1795.
[22] Gemmel F, Dumarey N, Welling M. Future diagnostic agents[J]. Semin Nucl Med, 2009, 39(1):11-26. DOI:10.1053/j.semnuclmed.2008.08.005.
[23] Tsopelas C. Radiotracers used for the scintigraphic detection of infection and inflammation[J/OL]. Scientific World Journal, 2015, 2015:676719[2018-02-02]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337049. DOI:10.1155/2015/676719.
[24] Rennen HJ, Boerman OC, Oyen WJ, et al. Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8[J]. J Nucl Med, 2001, 42(1):117-123.
[25] Rennen HJ, Bleeker-Rovers CP, van Eerd JE, et al. 99mTc-labeled interleukin-8 for scintigraphic detection of pulmonary infections[J]. Chest, 2004, 126(6):1954-1961. DOI:10.1378/chest.126.6.1954.
[26] Rennen HJ, Boerman OC, Oyen WJ, et al. Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection[J]. J Nucl Med, 2003, 44(9):1502-1509.
[27] Bleeker-Rovers CP, Rennen HJ, Boerman OC, et al. 99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation:first clinical evaluation[J]. J Nucl Med, 2007, 48(3):337-343.
[28] Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited[J]. Trends Immunol, 2002, 23(11):541-548.
[29] Wang ZG, Ye RD. Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice[J]. Gene, 2002, 299(1-2):57-63.
[30] Pollak A, Goodbody AE, Ballinger JR, et al. Imaging inflammation with 99Tcm-labeled chemotactic peptides:analogues with reduced neutropenia[J]. Nucl Med Commun, 1996, 17(2):132-139.
[31] Zhang Y, Kundu B, Fairchild KD, et al. Synthesis of novel neutrophil-specific imaging agents for Positron Emission Tomography (PET) imaging[J]. Bioorg Med Chem Lett, 2007, 17(24):6876-6878. DOI:10.1016/j.bmcl.2007.10.013.
[32] Stasiuk GJ, Holloway PM, Rivas C, et al. 99mTc SPECT imaging agent based on cFLFLFK for the detection of FPR1 in inflammation[J]. Dalton Trans, 2015, 44(11):4986-4993. DOI:10.1039/c4dt02980a.
[33] Yang X, Chordia MD, Du X, et al. Targeting formyl peptide receptor 1 of activated macrophages to monitor inflammation of experimental osteoarthritis in rat[J]. J Orthop Res, 2016, 34(9):1529-1538. DOI:10.1002/jor.23148.
[34] Pellico J, Lechuga-Vieco AV, Almarza E, et al. In vivo imaging of lung inflammation with neutrophil-specific 68Ga nano-radiotracer[J]. Sci Rep, 2017, 7(1):13242. DOI:10.1038/s41598-017-12829-y.
[35] Chen J, Cheng H, Dong Q, et al.[99mTc]cFLFLF for Early Diagnosis and Therapeutic Evaluation in a Rat Model of Acute Osteomyelitis[J]. Mol Imaging Biol, 2015, 17(3):337-344. DOI:10.1007/s11307-014-0787-3.
[36] Locke LW, Chordia MD, Zhang Y, et al. A novel neutrophil-specific PET imaging agent:cFLFLFK-PEG-64Cu[J]. J Nucl Med, 2009, 50(5):790-797. DOI:10.2967/jnumed.108.056127.
[37] Zhang Y, Kundu B, Zhong M, et al. PET imaging detection of macrophages with a formyl peptide receptor antagonist[J]. Nucl Med Biol, 2015, 42(4):381-386. DOI:10.1016/j.nucmedbio.2014.12.001.
[38] Locke LW, Kothandaraman S, Tweedle M, et al. Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma[J]. Tuberculosis (Edinb), 2018, 108:201-210. DOI:10.1016/j.tube.2018.01.001.
相似文献/References:
[1]李海军,程赢,乐晨,等.人外周血白细胞黏附分子的辐射效应研究[J].国际放射医学核医学杂志,2008,32(3):175.
LI Hai-jun,CHENG Ying,LE Chen,et al.Research on effects of ionizing radiation of human peripheral blood white cell adhesive molecules[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(3):175.
[2]林琛,王鲁华,李俊雄,等.131Ⅰ治疗Graves’甲状腺亢进症伴白细胞减少前后血清和尿中β2-微球蛋白变化分析[J].国际放射医学核医学杂志,2007,31(2):98.
LIN Chen,WANG Lu-hua,LI Jun-xiong,et al.Changes of serum and urine β2-microglobulin of leukopenia in hyperthyroidism of Graves’ disease before and after 131Ⅰ therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(3):98.
[3]李林法.18F-氟代脱氧葡萄糖正电子发射体层显像在感染与炎症病变中的应用[J].国际放射医学核医学杂志,2006,30(1):26.
LI Lin-fa.The application of 18F-fluorodeoxyglucose positron emission tomography in infection and inflammation[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(3):26.
[4]楚进锋,王学斌.感染和炎症显像剂的研究与应用[J].国际放射医学核医学杂志,2002,26(5):200.
CHU Jin-feng,WANG Xue-bin.Study and application of imaging agents for infection and inflammation[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(3):200.
[5]蒋茂松.炎症病灶核素定位显像[J].国际放射医学核医学杂志,1997,21(5):272.
[6]赵春雷,栗维国,罗锡圭,等.核医学炎症显像对临床炎症性疾病的评价[J].国际放射医学核医学杂志,1996,20(6):250.
[7]孟媛媛,杨福军,徐文清.乏氧诱导因子在疾病中作用机制的研究进展[J].国际放射医学核医学杂志,2017,41(5):347.[doi:10.3760/cma.j.issn.1673-4114.2017.05.008]
Meng Yuanyuan,Yang Fujun,Xu Wenqing.Review of retinal receptors and molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(3):347.[doi:10.3760/cma.j.issn.1673-4114.2017.05.008]